In light of a recent report suggesting that upregulation of PF-4 may play a crucial role in the early stages of several cancers [19], we propose here that upregulation of this peptide in our study was crucial in preventing angiogenesis at the tumor site in early prostate cancer. Here, PF4 is linked to Familial prostate cancer.